Faculty profile

Philippe Bedard

Back to faculty

ProfessorDepartment of MedicineUniversity of Toronto

Philippe Bedard

Professor

Department of Medicine

Temerty Faculty of Medicine

University of Toronto

Toronto, Ontario, Canada

ORCID

Supervision signals

Professors usually supervise graduate students in their department's programs.
11 publications in the last five years, latest in 2026.
Senior (last) author on 1 recent paper, a sign of leading a research group.
Supervised 1 trainee who won CIHR awards, most recently in 2010.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

University Profile Search on Google Scholar iDORCID

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Toronto profile.

Latest papers

Immune profiling by bulk RNA-seq and multiplex immunofluorescence imaging across multiple cancer types.
Frontiers in oncology · 2026
The role of stereotactic body radiotherapy in oligoprogressive breast cancer: A site-specific analysis of the prospective, phase-II RADIANT trial.
Clinical and translational radiation oncology · 2026
Impact of somatic PIK3CA mutations on clinical outcomes in HER2-positive breast cancer.
Breast cancer research : BCR · 2026

All 25 publications

Latest funding

LOBCAN: a prospective, multi-centre cohort study of treatment and outcomes for invasive LOBular breast carcinoma in CANada.
CIHR · 2024 · Co-investigator
$546,976
Triple negative breast cancer intratumour heterogeneity and disease progression
CIHR · 2022 · Co-investigator
$1,086,300
A Liquid-Biopsy Informed Platform Trial to Evaluate Treatment in CDK4/6-Inhibitor Resistant ER+/HER2- Metastatic Breast Cancer
CIHR · 2022 · Co-investigator
$2,184,076

All 11 grants and awards

25 publications.

Immune profiling by bulk RNA-seq and multiplex immunofluorescence imaging across multiple cancer types.

Gaspar C, Wu B, Stone SC, Sotov V, Wang B, Wangulu C, Berman H, Kay A, Basra P, Van de Laar E, Bratman S, Lheureux S, Knox J, Kim R, He H, Liu G, Bedard P, Spreafico A, Tsao M, Pugh TJ, Hansen A, Sapisochin G, Garcia ES, Siu LL, Bruce JP

Frontiers in oncology2026

DOI: 10.3389/fonc.2026.1876853 PMID: 42625601

The role of stereotactic body radiotherapy in oligoprogressive breast cancer: A site-specific analysis of the prospective, phase-II RADIANT trial.

Ruicci KM, Helou J, Barry A, Ye XY, Koch CA, Croke J, Han K, Rodin D, Hahn E, Kwan JYY, Yan M, Liu FF, Lindsay P, Javor J, Bedard P, Cescon D, Kumar V, Amir E, Nadler MB, Lee R, Glicksman RM

Clinical and translational radiation oncology2026

DOI: 10.1016/j.ctro.2026.101164 PMID: 42011409

Impact of somatic PIK3CA mutations on clinical outcomes in HER2-positive breast cancer.

Stabellini N, de Oliveira SD, Mizukami T, Sweeney SM, Schultz N, Kehl K, Riely G, Panageas K, Schrag D, Bedard P, Micheel C, Guo X, Montero AJ

Breast cancer research : BCR2026

DOI: 10.1186/s13058-026-02324-6 PMID: 42323696

Postchemotherapy orchiectomy in metastatic testicular germ cell tumors: Pathologic findings and predictors of residual viable disease.

Mousa A, Hayes J, Amiri A, Anson-Cartwright L, Atenafu EG, Bedard P, Jiang DM, Glicksman R, Chung P, Warde P, O'Malley M, Prendeville S, Hamilton RJ

Urologic oncology2026

DOI: 10.1016/j.urolonc.2026.111082 PMID: 41934019

Primary Retroperitoneal Lymph Node Dissection in Marker-Positive Clinical Stage II Nonseminomatous Germ Cell Tumors.

Mousa A, Chavarriaga J, Kaushal S, Burrafato Z, Anson-Cartwright L, Atenafu EG, Bedard P, Jiang DM, Glicksman R, Chung P, Warde P, O'Malley M, Prendeville S, Jewett MAS, Hamilton RJ

The Journal of urology2026

DOI: 10.1097/ju.0000000000004847 PMID: 41212998

Evaluation of ensilication technology for ambient DNA preservation.

Blas M, Yu C, Aghababazadeh FA, Hoelscher V, Volz M, Morales L, Jarolik K, Dong X, Dobin S, Rantasalo T, Hirvonen T, Pursiheimo JP, Laine N, Homer N, Chamoun C, Pierce W, Organick L, Fehr A, Becich M, Banal JL, Youens K, Tamminen M, Haibe-Kains B, Bedard P

NAR molecular medicine2026Senior author

DOI: 10.1093/narmme/ugag011 PMID: 41797988

The association of cancer-related fatigue on the social, vocational and healthcare-related dimensions of cancer survivorship

Jones JM, Howell D, Longo C, Olson K, Bedard P, Amir E, Zheng S, Chow B, Avery L

Journal of Cancer Survivorship202532 citationsOpen Access

DOI: 10.1007/s11764-023-01451-9 PMID: W4386243455

Primary retroperitoneal lymph node dissection for metastatic non-seminomatous germ cell tumours: outcomes and adjuvant chemotherapy.

Mousa A, Anson-Cartwright L, Atenafu EG, Jewett MAS, Bedard P, Jiang DM, Glicksman R, Chung P, Warde P, O'Malley M, Prendeville S, Hamilton RJ

BJU international2024

DOI: 10.1111/bju.16448 PMID: 38967557

Longitudinal efficacy and toxicity of SARS-CoV-2 vaccination in cancer patients treated with immunotherapy.

Spiliopoulou P, Janse van Rensburg HJ, Avery L, Kulasingam V, Razak A, Bedard P, Hansen A, Chruscinski A, Wang B, Kulikova M, Chen R, Speers V, Nguyen A, Lee J, Coburn B, Spreafico A, Siu LL

Cell death & disease2023

DOI: 10.1038/s41419-022-05548-4 PMID: 36670100

Role of Lactate Dehydrogenase in Identifying Relapse for Patients With Stage I Testicular Cancer on Surveillance.

Bobrowski A, Anson-Cartwright L, Kuhathaas K, Jiang DM, Chung P, Bedard P, Warde P, O'Malley M, Sweet J, Hamilton RJ

The Journal of urology2022

DOI: 10.1097/ju.0000000000002931 PMID: 35997696

Profile data last refreshed on September 25, 2026 from the university directory, publication records and CIHR, NSERC and SSHRC funding.

Something wrong or missing on this profile? Suggest a correction

Philippe Bedard

Research

Latest papers

Latest funding

Immune profiling by bulk RNA-seq and multiplex immunofluorescence imaging across multiple cancer types.

The role of stereotactic body radiotherapy in oligoprogressive breast cancer: A site-specific analysis of the prospective, phase-II RADIANT trial.

Impact of somatic PIK3CA mutations on clinical outcomes in HER2-positive breast cancer.

Postchemotherapy orchiectomy in metastatic testicular germ cell tumors: Pathologic findings and predictors of residual viable disease.

Primary Retroperitoneal Lymph Node Dissection in Marker-Positive Clinical Stage II Nonseminomatous Germ Cell Tumors.

Evaluation of ensilication technology for ambient DNA preservation.

The association of cancer-related fatigue on the social, vocational and healthcare-related dimensions of cancer survivorship

Primary retroperitoneal lymph node dissection for metastatic non-seminomatous germ cell tumours: outcomes and adjuvant chemotherapy.

Longitudinal efficacy and toxicity of SARS-CoV-2 vaccination in cancer patients treated with immunotherapy.

Role of Lactate Dehydrogenase in Identifying Relapse for Patients With Stage I Testicular Cancer on Surveillance.

Frequent collaborators

Eitan Amir

Lisa Avery

Fei-Fei Liu

Anna Spreafico

Abha Gupta

Meredith Giuliani

Ellen Greenblatt

Lisa Wang

Mojgan Hodaie

Mark Clemons

Vuk Stambolic

Benjamin Haibe-Kains

Bryan Coburn

Doris Howell

Vathany Kulasingam

Andrzej Chruscinski

Wendy Parulekar

Timothy Whelan

Scott Bratman

David Cescon

Lillian Siu

Kathy Han

Alexandra Easson